Basco, Renilda V.
HRN: 21-88-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2024
CEFUROXIME 500MG (TAB)
09/09/2024
09/15/2024
PO
500
Bid
Thinly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes